Ftse Mib
34.654,28
0,47%
DAX
18.596,40
0,61%
S&P 500
5.272,62
-0,09%
NASDAQ
16.771,66
0,22%
Bitcoin
69.108,00
2,01%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Allurion Technologies Inc (ALUR) Allurion Technologies Inc (ALUR) Notizie

ALUR

Allurion Technologies (ALUR)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:ALUR
DataOraFonteTitoloSimboloCompagnia
30/05/202414:00Business WireAllurion Announces Expansion of AI Weight Loss Coach to Support Patients on GLP-1sNYSE:ALURAllurion Technologies Inc
29/05/202422:05Business WireAllurion to Participate in Two Upcoming Investor Conferences in June 2024NYSE:ALURAllurion Technologies Inc
15/05/202414:00Business WireAllurion Announces Three Scientific Presentations at the European Congress on Obesity, Including Study on Lean Mass Preservation for Sustainable, Healthy Weight LossNYSE:ALURAllurion Technologies Inc
14/05/202422:39Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:ALURAllurion Technologies Inc
14/05/202414:05Edgar (US Regulatory)Form 8-K - Current reportNYSE:ALURAllurion Technologies Inc
14/05/202414:00Business WireAllurion Reports First Quarter 2024 Financial Results and Provides Business UpdateNYSE:ALURAllurion Technologies Inc
08/05/202401:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ALURAllurion Technologies Inc
02/05/202414:00Business WireAllurion Announces Three Scientific Presentations at IFSO-European Chapter 2024, Including First-Ever 3-Year Weight Maintenance SurveyNYSE:ALURAllurion Technologies Inc
30/04/202414:30Business WireAllurion Announces Preliminary First Quarter 2024 ResultsNYSE:ALURAllurion Technologies Inc
17/04/202414:31Business WireAllurion Closes $48 Million Convertible Senior Secured Note Financing with RTW InvestmentsNYSE:ALURAllurion Technologies Inc
04/04/202414:00Business WireAllurion Expands Virtual Care Suite to the United StatesNYSE:ALURAllurion Technologies Inc
21/03/202413:00Business WireAllurion Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 GuidanceNYSE:ALURAllurion Technologies Inc
13/03/202413:30Business WireAllurion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services ConferenceNYSE:ALURAllurion Technologies Inc
12/03/202413:00Business WireMilena Alberti-Perez Joins Allurion Board of Directors as Audit Committee ChairNYSE:ALURAllurion Technologies Inc
04/03/202414:30Business WireAllurion to Report Fourth Quarter 2023 Financial Results on March 21, 2024NYSE:ALURAllurion Technologies Inc
20/02/202422:05Business WireAllurion to Participate in Cowen’s 44th Annual Health Care ConferenceNYSE:ALURAllurion Technologies Inc
08/02/202414:30Business WireAllurion to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools ConferenceNYSE:ALURAllurion Technologies Inc
29/01/202414:00Business WireBrendan Gibbons Appointed Chief Legal Officer at Allurion TechnologiesNYSE:ALURAllurion Technologies Inc
23/01/202415:04Business WireSomerset NHS Foundation Trust Treats First Patients with Allurion Balloon for Pre-Surgical Weight LossNYSE:ALURAllurion Technologies Inc
23/01/202414:15Business WireWorld first : Somerset NHS Foundation Trust Treats First Patients with Allurion Balloon for Pre-Surgical Weight LossNYSE:ALURAllurion Technologies Inc
17/01/202414:00Business WireAllurion's Virtual Care Suite Digital Platform Accelerates Commercial Expansion With New Strategic PartnershipsNYSE:ALURAllurion Technologies Inc
11/01/202414:00Business WireAllurion Announces Publication of Randomized, Double-Blind Study Demonstrating Significant Improvement in Obesity-Related Co-MorbiditiesNYSE:ALURAllurion Technologies Inc
08/01/202414:00Business WireAllurion Announces Preliminary Fourth Quarter and Full Year 2023 Results and Provides 2024 OutlookNYSE:ALURAllurion Technologies Inc
05/01/202414:00Business WireNew research highlights the positive impact of GLP-1s and other anti-obesity medications on the Allurion ProgramNYSE:ALURAllurion Technologies Inc
02/01/202414:00Business WireAllurion’s Digital Platform Gains Traction with Expanded Strategic PartnershipNYSE:ALURAllurion Technologies Inc
13/11/202314:00Business WireAllurion Reports Third Quarter 2023 Financial Results and Provides Business UpdateNYSE:ALURAllurion Technologies Inc
06/11/202322:05Business WireAllurion to Participate in the Jefferies London Healthcare ConferenceNYSE:ALURAllurion Technologies Inc
06/11/202314:00Business WireAllurion to Report Third Quarter 2023 Financial Results on November 13, 2023NYSE:ALURAllurion Technologies Inc
11/10/202314:00Business WireAllurion Completes Enrollment in Pivotal AUDACITY Trial for the Allurion BalloonNYSE:ALURAllurion Technologies Inc
04/10/202314:00Business WireAllurion Announces Acceptance of Five Abstracts for Presentation at Obesity Week 2023NYSE:ALURAllurion Technologies Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:ALUR

La tua Cronologia

USOTC
AEXE
Aim Exploration (CE)
GEMN
BATETH
Basic Attention Token
LSE
CWGB
COIN
VNBTC
NASDAQ
RXIIW
LSE
45FD
Hsbc Bk. 24
LSE
TE36
Citi Fun 25
BIT
UC5T0Y
Unicredit Bank
COIN
TICKGBP
BIT
UC0HKN
Unicredit Bank
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network